PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective lifted by The Goldman Sachs Group from $18.00 to $32.00 in a report published on Tuesday, Benzinga reports. The Goldman Sachs Group currently has a sell rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on the stock. Citigroup raised their target […]
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $43.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 53.52% from the company’s […]
FormFactor, Inc. (NASDAQ:FORM – Get Free Report) Director Rebeca Obregon-Jimenez sold 4,833 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $57.59, for a total transaction of $278,332.47. Following the transaction, the director now directly owns 10,598 shares in the company, valued at […]
GameStop Corp. (NYSE:GME – Get Free Report) shares dropped 0.9% during mid-day trading on Thursday . The company traded as low as $20.10 and last traded at $21.04. Approximately 6,051,787 shares were traded during trading, a decline of 60% from the average daily volume of 15,217,870 shares. The stock had previously closed at $21.24. Analyst […]
Birkenstock (NYSE:BIRK – Free Report) had its target price upped by Robert W. Baird from $58.00 to $65.00 in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other brokerages have also issued reports on BIRK. BMO Capital Markets raised their […]